Inaktiver Wert

Andere Sprachen Forty Seven, Inc.

Aktien

A2JNTD

US34983P1049

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

FORTY SEVEN, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	07.04.20
Forty Seven, Inc.(NasdaqGS:FTSV) dropped from S&P TMI Index	07.04.20
Forty Seven, Inc.(NasdaqGS:FTSV) dropped from S&P Global BMI Index	07.04.20
Gilead Sciences, Inc. completed the acquisition of Forty Seven, Inc..	06.04.20
FORTY SEVEN : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	20.03.20
Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights	20.03.20
Forty Seven, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	20.03.20
Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia	11.03.20
Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia	11.03.20
Certain Common Stock of Forty Seven, Inc. are subject to a Lock-Up Agreement Ending on 11-MAR-2020.	11.03.20
Certain Stock Options of Forty Seven, Inc. are subject to a Lock-Up Agreement Ending on 11-MAR-2020.	11.03.20
Forty Seven : Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal	03.03.20
Forty Seven : Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline	02.03.20
Dow Jones Industrial Average : Les valeurs à suivre à Wall Street	02.03.20
Forty Seven : Gilead to Acquire Forty Seven for $4.9 Billion	02.03.20
FORTY SEVEN, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	02.03.20
Gilead Sciences : buying Forty Seven for $4.9 billion	02.03.20
Gilead Sciences, Inc. entered into a definitive agreement to acquire Forty Seven, Inc. for $4.6 billion.	02.03.20
VMware : Beyond Meat, Dell fall; 3M, Forty Seven rise	28.02.20
Gilead Sciences Reportedly Approaches Forty Seven with a Takeover Offer	28.02.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Forty Seven, Inc.

Aktien

A2JNTD

US34983P1049

Andere Sprachen

Filter